Figure 2
From: Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
Overall survival rate of patients with portal vein thrombosis (n = 60). In the overall survival study, the median survival time (MST) was 4.2 years in patients with portal vein thrombosis, with a 1-year survival rate of 70.7% and a 5-year survival rate of 47.9%. Deaths other than liver disease were censored. There were no liver transplant patients. OS, overall survival; MST, median survival time.
